Portfolio company
Serpenta
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Serpenta develops robotic surgical systems for endoluminal procedures to improve precision and recovery for patients undergoing colorectal surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SafeHeal
The company develops an endoluminal bypass sheath for colorectal surgery patients to prevent faecal contact with healing tissue and avoid temporary ostomies.
ROBOTIC MICROSURGERY
This company develops robotic surgical systems featuring miniaturised wristed instruments to assist surgeons in performing complex open microsurgery on delicate human tissues.
Ronovo Surgical
This company develops modular robotic surgery platforms for hospitals to perform minimally invasive procedures across multiple surgical specialties.
Dexterous Endoscopes
This company develops variable stiffness endoscopes for surgeons and hospitals to perform minimally invasive ear, nose and throat procedures.
SATA Medical
This company develops reusable, articulating laparoscopic and robotic surgical instruments for hospitals and surgeons performing minimally invasive procedures.
Virtual Incision
This company develops a miniaturised robotic-assisted surgery system for use by surgeons and hospitals in colorectal and gynaecological procedures.
Implican
This company develops a ring-based compression device for colorectal surgeons to create secure intestinal connections and reduce post-operative leakage.
Mendaera
Mendaera develops a handheld robotic platform with ultrasound imaging for healthcare providers to perform precise needle-based medical procedures.
